Detection of beta-endorphin in the cerebrospinal fluid after intrastriatal microinjection into the rat brain.
We have investigated to what extent microinjected beta-endorphin could migrate from the rat brain parenchyma into the CSF compartment. Exogenous rat beta-endorphin (0.1 nmol) was microinjected into the left striatum 1 mm from the lateral ventricle in anesthetized male rats. CSF samples were collected at different time points up to 2 h post-injection from a catheter affixed to the atlanto-occipital membrane of the cisterna magna. Radioimmunoassay and mass spectrometry were performed on the CSF samples, and brain sections were immunostained for beta-endorphin and mu-opioid receptors. The beta-endorphin injected rats showed a marked increase in beta-endorphin immunoreactive (IR) material in the CSF, with a peak at 30-45 min post-injection, and this beta-endorphin-IR material existed mainly as the intact beta-endorphin peptide. The immunohistochemistry results revealed the appearance of distinct beta-endorphin-IR cell bodies in the globus pallidus and the bed nucleus of stria terminalis supracapsular part, regions distant from the injection site, at 2 h post-injection of exogenous beta-endorphin. The beta-endorphin-IR in several of the globus pallidus cell bodies colocalized with the mu-opioid receptor-IR at the cell surface. These findings show that upon delivery of synthetic beta-endorphin, there is a significant intracerebral spread of the injected peptide, reaching regions far from the site of injection via diffusion in the extracellular space and flow in the cerebrospinal fluid. This may be of relevance when interpreting studies based on intracerebral injections of peptides, and advances our knowledge regarding the migration of compounds within the brain.
Höistad
Malin
M
Department of Neuroscience, Karolinska Institutet, Retziusv. 8, 17177 Stockholm, Sweden. Malin.Hoistad@neuro.ki.se
Samskog
Jenny
J
Jacobsen
Kirsten X
KX
Olsson
Annika
A
Hansson
Hans-Arne
HA
Brodin
Ernst
E
Fuxe
Kjell
K
D000818:Animals; D002555:Cerebrospinal Fluid / Q000737:chemistry* / Q000502:physiology; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism*; D004058:Diffusion; D005110:Extracellular Space / Q000187:drug effects* / Q000378:metabolism; D005917:Globus Pallidus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D007150:Immunohistochemistry; D020547:Lateral Ventricles / Q000502:physiology; D008297:Male; D013058:Mass Spectrometry; D008845:Microinjections; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D011863:Radioimmunoassay; D051381:Rats; D017207:Rats, Sprague-Dawley; D017450:Receptors, Opioid, mu / Q000187:drug effects / Q000378:metabolism; D012686:Septal Nuclei / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors; D001615:beta-Endorphin / Q000008:administration & dosage / Q000134:cerebrospinal fluid* / Q000493:pharmacokinetics*
D017450:Receptors, Opioid, mu; D001615:beta-Endorphin